Periodically investor groups coordinate public statements or letters in support of various initiatives or policies related to sustainability, environmental, social and governance (ESG) issues, and other materials investment considerations. The Intentional Endowments Network shares these statements here as opportunities for endowments to add their names and offer support, at their own discretion. If you have any questions, please contact us and we can connect you with the organizer(s) of the statements.
Deadline: May 3, 2019
As You Sow invites investors to sign onto the attached investor statement focused on increasing corporate disclosures related to gender equity. Currently, investors have a paucity of gender and workplace equity data. According to Equileap, an Amsterdam based non-profit gender research aggregator, only 37% of desired gender equality data is publicly reported. Data is lacking across 19 gender equality criteria, including the gender balance of the workforce and executive team, equal pay, parental leave, non-discriminatory hiring and promotion, and supply chain safety. Equileap's research is used to create an annual global ranking of companies leading the way in gender equity. This data set is essential to As You Sow's Gender Equality Funds. As such, we have drafted the attached sign-on letter to encourage companies to take seriously the need to report publicly on key gender equity indicators.
With governments around the world struggling to limit the increasing costs of healthcare budgets, it is clear that how pharmaceutical companies manage access-to-medicine risks and opportunities is material to their investors. The Access to Medicine Index is one of the most credible sources of information about how 20 of the world's largest pharmaceutical companies manage a range of value drivers within their business, including pricing models, R&D, governance and compliance. The 6th Access to Medicine Index was published in November 2018.
The Access to Medicine Foundation invites the investor community, including college and university endowments, to sign on the Investor Statement of the Access to Medicine Index, committing to take into account the analysis generated from the Index in their ESG analysis and engagement with pharmaceutical companies. To date, 89 investors collectively managing assets in excess of USD 11 trillion have already signed the Statement.
PRI invites investors to sign on to a statement committing to support a just transition on climate change. Investors can make an important contribution as stewards of assets, allocators of capital and as influential voices in public policy to make sure that the transition produces inclusive and sustainable development
* Please visit the past sign-on opportunities page to review older letters and statements, and the endowment signatories.